SCHEMBL8284369

SCHEMBL8284369

COc1ccc2c(O[C@@H]3C[C@H]4C(=O)NC5(C(N)=O)C[C@H]5/C=C\CCCCN(N)C(=O)[C@@H]4C3)cc(-c3ccccc3)nc2c1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.72
▸ CTSS P25774 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ADRB3 P13945 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ TACR3 P29371 5/20 0.34
▸ TDP1 Q9NUW8 3/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MITF O75030 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ PAX8 Q06710 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3277879 0.93 CTSB (0.69) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL13413197 0.90 CTSB (0.89) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL13248866 0.90 CTSB (0.89) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL12017053 0.89 CTSB (0.81) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL19093889 0.89 CTSB (0.81) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL13385474 0.88 CTSB (0.71) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL8244871 0.88 CTSB (0.71) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3053173 0.87 CTSB (0.84) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL13291500 0.86 CTSB (0.63) CTSBCTSSKDM4EALDH1A1SMN1; SMN2
SCHEMBL13291501 0.86 CTSB (0.63) CTSBCTSSKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005073195-A2 HCV NS-3 SERINE PROTEASE INHIBITORS MEDIVIR AB (SE) 2005-08-11 — — WO disclosed
Send feedback